RT
Insider selling
Rahsaan Thompson sold $20K of Zevra Therapeutics, Inc. (ZVRA) stock
Rahsaan Thompson, Chief Legal & Compliance of Zevra Therapeutics, Inc. (ZVRA), sold 1,794 shares of ZVRA stock worth $20K, per an SEC Form 4 filed May 13, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 11, 2026, 2 days before it was made public.
ZVRA has moved +8.1% since the trade date, from $10.80 to $11.67 (Sep 21, 2026 close).
- Traded
- May 11, 2026
- Disclosed
- May 13, 2026
- Filing delay
- 2 days
- Price since
- +8.1%
- Role
- Chief Legal & Compliance
- Source
- SEC Form 4
More ZVRA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.